newsfilter
← Latest News
Business Wire·

CareDx Announces Finalization of Solid Organ Transplant Molecular Testing Local Coverage Determination

Coverage for Surveillance Testing Affirmed for Early Detection of Allograft Rejection in Kidney, Heart, and Lung CareDx, Inc. (NASDAQ:CDNA), a leading precision medicine diagnostics company in transplant, specialty